PGR and breast cancer: Niedźwiecki et al23 found that the expression level of miR‐200c was lower in TNBC patients' serum when compared with the levels in the ER/PR‐positive group, revealing that miR‐200c is a diagnostic biomarker to distinguish the subtype of breast cancer.